Prostate Cancer - Results from #25660

The dose-response of the anal sphincter region - an analysis of data from the MRC RT01 trial - Abstract June 11, 2012

Do we need to obtain consent for penile shortening as a complication of treatment for organ-confined prostate cancer? - Abstract June 11, 2012

Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy - Abstract June 11, 2012

Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice - Abstract June 11, 2012

Prostate cancer: Promising biomarkers related to aggressive disease - Abstract June 11, 2012

Improved differentiation between ductal and acinar prostate cancer using three-dimensional histology and biomarkers - Abstract June 11, 2012

Measurement of patient imaging dose for real-time kilovoltage x-ray intrafraction tumour position monitoring in prostate patients - Abstract June 11, 2012

Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era - Abstract June 11, 2012

Use of [-2] pro PSA and phi index for early detection of prostate cancer: A prospective of 452 patients - Abstract June 11, 2012

Association of radiotherapy and hormonotherapy in locally advanced prostate cancer - Abstract June 11, 2012

Primary care providers' perspectives on discontinuing prostate cancer screening - Abstract June 10, 2012

Immunotherapy: An emerging strategies against prostate castration resistant cancer - Abstract June 9, 2012

Prostate cancer and chemotherapy: Standards care and perspectives - Abstract June 9, 2012

Management of metastatic castration-resistant prostate cancer following docetaxel - Abstract June 9, 2012

Performance characteristics of prostate-specific antigen in patients undergoing radical prostatectomy - Abstract June 9, 2012

Is statin use associated with D'Amico risk groups and biochemical recurrence after radical prostatectomy? - Abstract June 9, 2012

Androgens, diabetes and prostate cancer - Abstract June 8, 2012

Long-term recovery of irradiated prostate cancer increases cancer stem cells - Abstract June 8, 2012

A phantom study to assess accuracy of needle identification in real-time planning of ultrasound-guided high-dose-rate prostate implants - Abstract June 8, 2012

Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: The benefits of hypofractionated over conventionally fractionated radiotherapy - Abstract June 8, 2012

Page 1284 of 1436